Thank you, Chair.
I have just a few questions. Being from New Brunswick, I probably want to lean that way a little bit.
On the sea lice issue, I think in New Brunswick there is concern about some immunity being built up. Maybe there are some lessons learned that could be gained out of this, but I think the industry is actually looking at other types of medications they can use. Is there some process or are there any new medications that are being looked at? One of the things that has been discussed is an idea of, rather than letting a medication run out, actually rotating the medications over a period of two or three years.
Can you give us some thoughts on that?